A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 2529 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 2529 To increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES July 30, 2025 Mr. Husted (for himself and Ms. Hassan) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. INCREASING THE CLARITY AND PREDICTABILITY OF THE PROCESS FOR DEVELOPING APPLICATIONS FOR RX-TO-NONPRESCRIPTION SWITCHES. (a) In General.--Section 505(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(b)) is amended by adding at the end the following: ``(7) Rx-to-nonprescription switches.-- `…